{"schema_version":"1","generated_at":"2026-11-01T06:38:49.597Z","data_as_of":null,"url":"https://www.findmykol.com/kol/lara-ronan","json_url":"https://www.findmykol.com/kol/lara-ronan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"lara-ronan","name":"Lara Ronan","credential":"MD","specialty":"Neurology","specialty_raw":"Neurology","therapeutic_area":"Neurology","therapeutic_areas":["Neurology"],"institution":"Dartmouth–Hitchcock Medical Center","institution_url":"https://www.findmykol.com/institution/dartmouth-hitchcock-medical-center","city":"Lebanon","state":"NH","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1750382693","orcid":"0000-0001-7022-4569","openalex":"A5082523837"},"summary":"Lara Ronan is a Neurology physician affiliated with Dartmouth–Hitchcock Medical Center. OpenAlex indexes 18 publications with 257 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Neurology"]},"scholarship":{"works_count":18,"cited_by_count":257,"h_index":5,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02071056","title":"Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)","status":"COMPLETED","role":"Overall official","sponsor":"Dartmouth-Hitchcock Medical Center","source_url":"https://clinicaltrials.gov/study/NCT02071056","trial_url":"https://www.findmykol.com/trial/NCT02071056"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2025,"amount_usd":46.9,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750382693"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1750382693","source":"payments"},"prescribing":{"data_year":2021,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":1,"classes":[{"class":"Other antiepileptics","setting":"prescribed","share_pct":100,"drugs":[{"name":"Levetiracetam","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2020,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":14,"shown":5,"withheld":9,"matched_by":"OpenAlex author record","recent":[{"title":"Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations","year":2022,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.21.02371","status":"verified"},{"title":"A Novel Graphic Medicine Curriculum for Resident Physicians: Boosting Empathy and Communication through Comics","year":2020,"journal":"Journal of Medical Humanities","source_url":"https://doi.org/10.1007/s10912-020-09654-2","status":"verified"},{"title":"Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report","year":2020,"journal":"Case Reports in Oncology","source_url":"https://doi.org/10.1159/000504930","status":"verified"},{"title":"A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)","year":2019,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noz232","status":"verified"},{"title":"Arts Intervention for Inpatients with Refractory Epilepsy or Migraine: Pilot Feasibility Study (P3.9-065)","year":2019,"journal":"Neurology","source_url":"https://doi.org/10.1212/wnl.92.15_supplement.p3.9-065","status":"verified"}],"source":"works"},"contact":{"address_1":"1 MEDICAL CENTER DR","address_2":"DHMC - DEPT OF NEUROLOGY","city":"Lebanon","state":"NH","zip":"037561000","phone":"603-650-7491","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1750382693","source":"identity"},"similar":[{"name":"Kenneth Meehan","slug":"kenneth-meehan","institution":"Dartmouth–Hitchcock Medical Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/kenneth-meehan","json_url":"https://www.findmykol.com/kol/kenneth-meehan/profile.json"},{"name":"Thamolwan Surakiatchanukul","slug":"thamolwan-surakiatchanukul","institution":"Dartmouth–Hitchcock Medical Center","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/thamolwan-surakiatchanukul","json_url":"https://www.findmykol.com/kol/thamolwan-surakiatchanukul/profile.json"},{"name":"Payam Moein","slug":"payam-moein","institution":"Dartmouth–Hitchcock Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/payam-moein","json_url":"https://www.findmykol.com/kol/payam-moein/profile.json"},{"name":"Linda Vahdat","slug":"linda-vahdat","institution":"Dartmouth–Hitchcock Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/linda-vahdat","json_url":"https://www.findmykol.com/kol/linda-vahdat/profile.json"},{"name":"Bruce Miller","slug":"bruce-miller","institution":"University of California, San Francisco (UCSF)","specialty":"Neurology","url":"https://www.findmykol.com/kol/bruce-miller","json_url":"https://www.findmykol.com/kol/bruce-miller/profile.json"},{"name":"Brett Kissela","slug":"brett-kissela","institution":"Medical College of Wisconsin","specialty":"Neurology","url":"https://www.findmykol.com/kol/brett-kissela","json_url":"https://www.findmykol.com/kol/brett-kissela/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"Richard Lipton","slug":"richard-lipton","institution":"Albert Einstein College of Medicine","specialty":"Neurology","url":"https://www.findmykol.com/kol/richard-lipton","json_url":"https://www.findmykol.com/kol/richard-lipton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":9}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-10-14","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2021}},"methodology_url":"https://www.findmykol.com/about#methodology"}